GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 2,610.00
-100.00 (-3.69%)
At close: Aug 21, 2026
GC Medical Science Market Cap
GC Medical Science has a market cap or net worth of 56.75 billion as of August 21, 2026. Its market cap has decreased by -33.08% in one year.
Market Cap
56.75B
Enterprise Value
77.30B
Revenue
105.48B
Ranking
n/a
PE Ratio
15.15
Stock Price
2,610.00
ChartMarket Cap Chart
Since December 17, 2014, GC Medical Science's market cap has decreased from 98.95B to 56.75B, a decrease of -42.65%. That is a compound annual growth rate of -4.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 56.75B | -34.83% |
| Dec 30, 2025 | 87.08B | 12.05% |
| Dec 30, 2024 | 77.71B | -22.72% |
| Dec 28, 2023 | 100.56B | -17.47% |
| Dec 29, 2022 | 121.86B | -20.00% |
| Dec 30, 2021 | 152.32B | -53.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 244.10B |
| 3billion | 172.48B |
| GENINUS | 78.78B |
| Cytogen | 72.78B |
| Protia | 61.57B |
| Inventera | 58.21B |
| HLB Panagene | 51.58B |
| Seoulin Bioscience | 38.20B |